Outcome of conservative treatment and subsequent assisted reproductive technology for patients with early-stage endometrial adenocarcinoma and poor fertility potential

被引:2
|
作者
Tong Xiao-mei [1 ]
Zhu Hai-yan [1 ]
Lin Xiao-na [1 ]
Jiang Ling-ying [1 ]
Xu Wei-hai [1 ]
Liu Liu [1 ]
Zhang Song-ying [1 ]
机构
[1] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Assisted Reprod Unit,Dept Obstet & Gynecol, Hangzhou 310016, Zhejiang, Peoples R China
关键词
endometrial carcinoma; progestin; assisted reproductive technology; IN-VITRO FERTILIZATION; CANCER; STIMULATION; HYPERPLASIA; MANAGEMENT;
D O I
10.3760/cma.j.issn.0366-6999.2012.19.040
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Conservative treatment with high doses of progestin is an alternative to standard hysterectomy for young patients with early-stage endometrial adenocarcinoma who desire to preserve their fertility. Here we report a patient with well-differentiated early-stage endometrial adenocarcinoma and poor fertility potential who failed to become pregnant in two in vitro fertilization-embryo transfer cycles and suffered a relapse after conservative treatment. This case illustrates that assessment of fertility potential is critical at the time of initial evaluation and conservative treatment planning for patients with endometrial adenocarcinoma. Chin Med J 2012;125(19):3578-3580
引用
收藏
页码:3578 / 3580
页数:3
相关论文
共 50 条
  • [21] THE OUTCOMES OF FERTILITY SPARING TREATMENT FOR EARLY STAGE WELL-DIFFERENTIATION ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA
    Lin, H.
    Ou, Y. C.
    Wu, C. H.
    Liu, S. C.
    Fu, H. C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 434 - 434
  • [22] THE OUTCOMES OF FERTILITY SPARING TREATMENT FOR EARLY STAGE WELL-DIFFERENTIATION ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA
    Lin, H.
    Ou, Y. C.
    Wu, C. H.
    Liu, S. C.
    Fu, H. C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1138 - 1138
  • [23] Fertility-preserving treatment in patients with early-stage endometrial cancer A protocol for systematic review and meta-analysis
    Zhao, Xiao-Li
    Du, Ze-Qing
    Zhang, Xuan
    Yao, Zhi
    Liang, Ying-Qiu
    Zhao, Su-Fen
    MEDICINE, 2021, 100 (48)
  • [24] Conservative management of early-stage endometrial cancer for fertility preservation: a survey study among Swedish gynecologists and gynecological oncologists
    Iliadis, Stavros I. I.
    Gambadauro, Pietro
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [25] Conservative management of early-stage endometrial cancer for fertility preservation: a survey study among Swedish gynecologists and gynecological oncologists
    Stavros I. Iliadis
    Pietro Gambadauro
    Scientific Reports, 13
  • [26] Elevated hepatocyte growth factor level correlates with poor outcome in early-stage and late-stage adenocarcinoma of the lung
    Siegfried, JM
    Luketich, JD
    Stabile, LP
    Christie, N
    Land, SR
    CHEST, 2004, 125 (05) : 116S - 119S
  • [27] Lymphovascular invasion is a significant predictor for distant recurrence in patients with early-stage endometrial endometrioid adenocarcinoma
    Nofech-Mozes, Sharon
    Ackerman, Ida
    Ghorab, Zeina
    Ismiil, Nadia
    Thomas, Gillian
    Covens, Al
    Khalifa, Mahmoud A.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 129 (06) : 912 - 917
  • [28] Analysis of IVF/ICSI outcomes in infertile women with early-stage endometrial cancer and atypical endometrial hyperplasia after conservative treatment
    Guo, Yaxing
    Zong, Xuan
    Li, Hongzhen
    Qiao, Jie
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2022, 39 (07) : 1643 - 1651
  • [29] Fertility-Sparing Surgery in Early-Stage Cervical Cancer Patients Oncologic and Reproductive Outcomes
    Ditto, Antonino
    Martinelli, Fabio
    Bogani, Giorgio
    Fischetti, Margherita
    Di Donato, Violante
    Lorusso, Domenica
    Raspagliesi, Francesco
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (03) : 493 - 497
  • [30] Preoperative anemia predicts poor outcome in surgically resected early-stage NSCLC patients
    Alexandra King
    Nature Clinical Practice Oncology, 2005, 2 (10): : 489 - 489